Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 20
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Br J Dermatol ; 176(5): 1224-1230, 2017 May.
Artigo em Inglês | MEDLINE | ID: mdl-27564228

RESUMO

BACKGROUND: Dermatomyositis (DM) is an autoimmune disease primarily affecting skin and muscle. OBJECTIVES: The purpose of this study was to determine whether an association exists between clinical skin disease activity as measured by the validated Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) and type 1 interferon (IFN) pathway biomarkers in the blood of patients with DM. METHODS: Forty-two patients with DM and 25 healthy volunteers were prospectively enrolled. CDASI scores were obtained, and serum and blood RNA were isolated from all participants. Associations between CDASI activity and type 1 IFN-inducible gene signature were assessed cross-sectionally in all patient samples and longitudinally on 13 paired visits via transcriptional profiling analyses. RESULTS: By RNAseq analysis, type 1 IFN-inducible genes were the most highly differentially regulated. A CDASI activity threshold of 12 was correlated with an elevated type 1 IFN gene signature and with serum IFN-ß, but not with IFN-α protein. Expression analysis showed that all patients with mild disease activity had a low type 1 IFN gene signature, while 93% of patients with moderate-to-high disease activity had elevated gene signature. In longitudinal analysis, changes in CDASI activity showed nonsignificant trends with concordant directional changes in gene signature. CONCLUSIONS: A type 1 IFN pathway signature biomarker in blood is highly correlated with CDASI activity scores in DM, and may be a promising surrogate clinical trial end point. The correlation of serum IFN-ß, but not IFN-α, with both a gene signature and CDASI suggests that IFN-ß drives disease activity in DM.


Assuntos
Dermatomiosite/genética , Interferon Tipo I/genética , Interferon beta/genética , Biomarcadores/metabolismo , Quimiocina CXCL10/metabolismo , Estudos Transversais , Dermatomiosite/sangue , Feminino , Voluntários Saudáveis , Humanos , Interferon Tipo I/metabolismo , Interferon beta/metabolismo , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , RNA Mensageiro/metabolismo , Índice de Gravidade de Doença
2.
Science ; 286(5439): 531-7, 1999 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-10521349

RESUMO

Although cancer classification has improved over the past 30 years, there has been no general approach for identifying new cancer classes (class discovery) or for assigning tumors to known classes (class prediction). Here, a generic approach to cancer classification based on gene expression monitoring by DNA microarrays is described and applied to human acute leukemias as a test case. A class discovery procedure automatically discovered the distinction between acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) without previous knowledge of these classes. An automatically derived class predictor was able to determine the class of new leukemia cases. The results demonstrate the feasibility of cancer classification based solely on gene expression monitoring and suggest a general strategy for discovering and predicting cancer classes for other types of cancer, independent of previous biological knowledge.


Assuntos
Perfilação da Expressão Gênica , Leucemia Mieloide/classificação , Leucemia Mieloide/genética , Leucemia-Linfoma Linfoblástico de Células Precursoras/classificação , Leucemia-Linfoma Linfoblástico de Células Precursoras/genética , Doença Aguda , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Adesão Celular/genética , Ciclo Celular/genética , Proteínas de Homeodomínio/genética , Humanos , Leucemia Mieloide/tratamento farmacológico , Proteínas de Neoplasias/genética , Neoplasias/classificação , Neoplasias/genética , Análise de Sequência com Séries de Oligonucleotídeos , Oncogenes , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamento farmacológico , Valor Preditivo dos Testes , Reprodutibilidade dos Testes , Resultado do Tratamento
3.
J Leukoc Biol ; 61(4): 533-8, 1997 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-9103242

RESUMO

First-generation replication-defective adenoviruses have been reported to lead to transient reporter gene expression due to a specific immune reaction involving T and B lymphocytes. Some recent reports have also demonstrated the presence of a nonspecific inflammatory reaction involving macrophages and neutrophils after both intramuscular injections and viral vectors transduction. To further investigate this nonspecific inflammatory reaction, deltaE1/E3a adenoviruses were injected intramuscularly in immunocompetent mice. Some of these mice were treated with anti-LFA-1. The adenovirus-injected muscles showed abundant CD4+, CD8+, LFA-1+, and Mac-1+ cell infiltration 3 days after the deltaE1/E3a injection. The anti-LFA-1 monoclonal antibody was able to block the nonspecific inflammatory damage due mostly to neutrophils and macrophages. The anti-LFA-1 did not produce this effect by reducing the muscle infiltration by LFA-1+ cells. It may instead have blocked the direct interaction between LFA-1 and ICAM-1 thus preventing the damage produced by the respiratory burst of neutrophils. Blocking the resulting damage of this inflammatory reaction with anti-LFA-1 in animals also treated with FK506, a powerful immunosuppressant for gene therapy, largely increased the long-term transgene expression compared with mice only treated with FK506.


Assuntos
Adenoviridae/fisiologia , Anticorpos Monoclonais/farmacologia , Inflamação/patologia , Inflamação/virologia , Antígeno-1 Associado à Função Linfocitária/imunologia , Replicação Viral , Animais , Linfócitos T CD4-Positivos/imunologia , Linfócitos T CD4-Positivos/patologia , Linfócitos T CD8-Positivos/imunologia , Linfócitos T CD8-Positivos/patologia , Imunossupressores/farmacologia , Inflamação/imunologia , Camundongos , Camundongos Endogâmicos C57BL , Ratos , Tacrolimo/farmacologia , Fatores de Tempo
4.
Transplantation ; 65(6): 793-9, 1998 Mar 27.
Artigo em Inglês | MEDLINE | ID: mdl-9539090

RESUMO

BACKGROUND: The inflammatory reaction that occurs during the 5 days after transplantation led at 3 days to the death of 70% of injected myoblasts. Use of anti-inflammatory agents appeared to be a possible way to increase myoblast survival. The application of gene transfer techniques to cell transplantation offers the potential for the prevention of inflammatory reaction. METHODS: In this study, transforming growth factor-beta1 (TGF-beta1) gene was introduced in myoblasts with a retroviral vector to permit the secretion of this anti-inflammatory cytokine. Survival of (1) infected myoblasts expressing TGF-beta1 or (2) normal myoblasts transplanted with genetically modified cloned myoblasts was compared with survival of normal myoblasts. RESULTS: Expression of TGF-beta1 by myoblasts or by cotransplanted cells decreased myoblast mortality after 3 days by roughly 20% (66.0+/-3.0% in control vs. 46.3+/-4.2% and 46.2+/-5.9%). The increase of myoblast survival by TGF-beta1 expression was correlated with a lower polymorphonuclear cell and macrophage infiltration in muscles compared with control. In addition, cytotoxicity of neutrophils against myoblasts was assayed in vitro. The oxidation of myoblasts by activated neutrophils was decreased after infection of the myoblasts with the TGF-beta1 retroviral vector. CONCLUSIONS: These data demonstrate that the insertion of TGF-beta1 decreases inflammatory reaction observed after myoblast transplantation and thus prolongs their survival.


Assuntos
Anti-Inflamatórios/farmacologia , Músculo Esquelético/transplante , Fator de Crescimento Transformador beta/farmacologia , Animais , Linhagem Celular , Células Cultivadas , Expressão Gênica , Humanos , Inflamação/patologia , Contagem de Leucócitos , Camundongos , Músculo Esquelético/citologia , Músculos/patologia , Neutrófilos , Peroxidase/metabolismo , Proteínas Recombinantes , Fator de Crescimento Transformador beta/genética
5.
Nucl Med Biol ; 23(2): 169-71, 1996 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-8868290

RESUMO

In vivo pharmacokinetic and brain binding characteristics of [18F]RP 62203, a selective high-affinity serotonergic 5-HT2A receptor antagonist, were assessed in the rat following intravenous injection of trace amount of the radioligand. The radioactive distribution profile observed in the brain 60 min after injection was characterized by greater than fourfold higher uptake in neocortex as compared to cerebellum (0.38 +/- 0.07% injected dose/g, % ID/g and 0.08 +/- 0.01 ID/g, respectively), consistent with in vivo specific binding to the 5-HT2A receptor. Furthermore, specific [18F]RP 62203 binding significantly correlated with the reported in vitro distribution of 5-HT2A receptors, but not with known concentration profiles of dopaminergic D2 or adrenergic alpha 1 receptors. Finally, detectable specific binding was abolished by pretreatment with large doses of ritanserin, a selective 5-HT2A antagonist, which resulted in uniform uptakes across cortical, striatal and cerebellar tissues. Thus, [18F]RP 62203 appears to be a promising selective tool to visualize and quantify 5-HT2A brain receptors in vivo with positron emission tomography.


Assuntos
Antagonistas Adrenérgicos beta/farmacocinética , Encéfalo/metabolismo , Óxidos S-Cíclicos/farmacocinética , Naftalenos/farmacocinética , Receptores de Serotonina/metabolismo , Antagonistas da Serotonina/farmacocinética , Animais , Encéfalo/diagnóstico por imagem , Radioisótopos de Flúor , Marcação por Isótopo , Masculino , Ensaio Radioligante , Ratos , Ratos Sprague-Dawley , Ritanserina/farmacologia , Distribuição Tecidual , Tomografia Computadorizada de Emissão
6.
Vet Microbiol ; 96(1): 69-79, 2003 Oct 08.
Artigo em Inglês | MEDLINE | ID: mdl-14516709

RESUMO

We investigated the genetic diversity of 179 Staphylococcus aureus isolates recovered from various sites in 10 farms producing cheeses manufactured with raw ewe's milk. Isolates were collected from handcrafted cheeses, bulk tank milk, milk from half-udders, skin abscesses on the udder if present, hands and anterior nares of farmers, and air of the milking area. The isolates were typed using pulsed-field gel electrophoresis (PFGE) of DNA SmaI digests and compared to other isolates of S. aureus isolated in different hosts or in different locations. The results showed that nine farms were contaminated by S. aureus isolates with identical banding patterns (named OV) or by genetically related isolates (named OV'). These dominant banding patterns were found in a variable proportion of the samples from each farm (range: 11-100%). Most of the strains isolated from nasal carriage or strains isolated from other regions or from other animal species had different PFGE patterns to OV or OV', except for three strains. These results show that a single clone of S. aureus is widely distributed both in infected mammary glands and in cheese produced from raw milk. This study confirms that infected mammary glands are the main source of the contamination of dairy products in sheep.


Assuntos
Eletroforese em Gel de Campo Pulsado/veterinária , Variação Genética , Doenças dos Ovinos/microbiologia , Infecções Estafilocócicas/veterinária , Staphylococcus aureus/classificação , Animais , Técnicas de Tipagem Bacteriana , Queijo/microbiologia , DNA Bacteriano/análise , Indústria de Laticínios , Eletroforese em Gel de Campo Pulsado/métodos , Feminino , França/epidemiologia , Genótipo , Humanos , Glândulas Mamárias Animais/microbiologia , Mastite/epidemiologia , Mastite/microbiologia , Mastite/veterinária , Leite/microbiologia , Mucosa Nasal/microbiologia , Ovinos , Doenças dos Ovinos/epidemiologia , Pele/microbiologia , Infecções Estafilocócicas/epidemiologia , Infecções Estafilocócicas/microbiologia , Staphylococcus aureus/genética , Staphylococcus aureus/isolamento & purificação
7.
AANA J ; 68(3): 241-4, 2000 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-11132012

RESUMO

Jet ventilation (JV) involves high-pressure ventilation for upper laryngeal laser procedures. Anesthetic management for the patient undergoing JV can be challenging, as complications of JV can include subcutaneous emphysema and tension pneumothorax. A 52-year-old woman with a diagnosis of vocal cord polyps presented for direct microlaryngoscopy and laser laryngoplasty with JV. Intraoperatively, the patient developed lack of bilateral chest movement and an audible change in jet-ventilatory sounds. The patient was reintubated with a standard endotracheal tube. Subsequent attempts to ventilate the patient failed. A diagnosis of bilateral tension pneumothorax was made. Immediate pleural decompression resulted in improved ventilatory and hemodynamic status. The purpose of this case report is to discuss the pathophysiology related to tension pneumothorax and anesthetic implications for management of cases involving JV.


Assuntos
Ventilação em Jatos de Alta Frequência/efeitos adversos , Complicações Intraoperatórias/etiologia , Pneumotórax/etiologia , Feminino , Humanos , Terapia a Laser , Pessoa de Meia-Idade , Enfermeiros Anestesistas , Pólipos/cirurgia , Prega Vocal/cirurgia
8.
Transl Psychiatry ; 2: e201, 2012 Dec 04.
Artigo em Inglês | MEDLINE | ID: mdl-23212585

RESUMO

Epidemiological and genome-wide association studies of severe psychiatric disorders such as schizophrenia (SZ) and bipolar disorder (BD), suggest complex interactions between multiple genetic elements and environmental factors. The involvement of genetic elements such as Human Endogenous Retroviruses type 'W' family (HERV-W) has consistently been associated with SZ. HERV-W envelope gene (env) is activated by environmental factors and encodes a protein displaying inflammation and neurotoxicity. The present study addressed the molecular characteristics of HERV-W env in SZ and BD. Hundred and thirty-six patients, 91 with BD, 45 with SZ and 73 healthy controls (HC) were included. HERV-W env transcription was found to be elevated in BD (P<10-4) and in SZ (P=0.012) as compared with HC, but with higher values in BD than in SZ group (P<0.01). The corresponding DNA copy number was paradoxically lower in the genome of patients with BD (P=0.0016) or SZ (P<0.0003) than in HC. Differences in nucleotide sequence of HERV-W env were found between patients with SZ and BD as compared with HC, as well as between SZ and BD. The molecular characteristics of HERV-W env also differ from what was observed in Multiple Sclerosis (MS) and may represent distinct features of the genome of patients with BD and SZ. The seroprevalence for Toxoplasma gondii yielded low but significant association with HERV-W transcriptional level in a subgroup of BD and SZ, suggesting a potential role in particular patients. A global hypothesis of mechanisms inducing such major psychoses is discussed, placing HERV-W at the crossroads between environmental, genetic and immunological factors. Thus, particular infections would act as activators of HERV-W elements in earliest life, resulting in the production of an HERV-W envelope protein, which then stimulates pro-inflammatory and neurotoxic cascades. This hypothesis needs to be further explored as it may yield major changes in our understanding and treatment of severe psychotic disorders.


Assuntos
Transtorno Bipolar/virologia , Variações do Número de Cópias de DNA/genética , Retrovirus Endógenos/genética , Genes env/genética , Esquizofrenia/virologia , Toxoplasmose/sangue , Transtorno Bipolar/sangue , Transtorno Bipolar/genética , Estudos de Casos e Controles , Retrovirus Endógenos/metabolismo , Humanos , Esclerose Múltipla/genética , Esclerose Múltipla/virologia , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Esquizofrenia/sangue , Esquizofrenia/genética
12.
Vaccine ; 27(2): 260-9, 2009 Jan 07.
Artigo em Inglês | MEDLINE | ID: mdl-18984025

RESUMO

To determine whether systemic immunization with plasmid DNA and virus vector against visna/maedi virus (VMV) would induce protective immune responses, sheep were immunized with VMV gag and/or env sequences using particle-mediated epidermal bombardment and injection of recombinant modified vaccinia Ankara. The results showed that immunization induced both humoral and cell-mediated responses prior to and after virus challenge. The vaccination protocol did not prevent infection, but immunization with the gag gene or a combination of gag and env genes resulted in significantly reduced provirus loads in blood and mediastinal lymph node, respectively. Provirus loads in lung and draining lymph node were unaffected, but p25 expression was undetectable in lungs of animals immunized with a combination of gag and env genes. Analysis of target tissues for lesions at post-mortem showed that immunization with the env gene caused a significant increase in lesion score, while the gag gene or a combination of gag and env genes had no effect. Inclusion of the ovine interferon-gamma gene in the initial priming mixture had minimal effect on immune responses, provirus load, or lesion development, although it resulted in a decreased p25 expression in the lung. The results thus show that systemic immunization with gag or a combination of gag and env genes reduces provirus load in blood and lymphoid tissue, respectively whereas env immunization has no effect on provirus load but increased lesion development.


Assuntos
Biolística , Genes env/genética , Genes gag/genética , Pneumonia Intersticial Progressiva dos Ovinos/prevenção & controle , Vacinas de DNA , Vaccinia virus/genética , Animais , Anticorpos Antivirais/sangue , Epiderme/virologia , Feminino , Genes env/imunologia , Genes gag/imunologia , Imunização , Masculino , Pneumonia Intersticial Progressiva dos Ovinos/virologia , Provírus/isolamento & purificação , Ovinos , Linfócitos T/imunologia , Vacinas de DNA/administração & dosagem , Vacinas de DNA/genética , Vacinas de DNA/imunologia , Vaccinia virus/imunologia , Vacinas Virais/administração & dosagem , Vacinas Virais/genética , Vacinas Virais/imunologia , Vírion/genética , Vírion/imunologia , Vírus Visna-Maedi
13.
Vaccine ; 26(35): 4494-505, 2008 Aug 18.
Artigo em Inglês | MEDLINE | ID: mdl-18606204

RESUMO

Sheep were immunized against Visna/Maedi virus (VMV) gag and/or env genes via the nasopharynx-associated lymphoid tissue (NALT) and lung using polyethylenimine (PEI)-DNA complexes and modified vaccinia Ankara, and challenged with live virus via the lung. env immunization enhanced humoral responses prior to but not after VMV challenge. Systemic T cell proliferative and cytotoxic responses were generally low, with the responses following single gag gene immunization being significantly depressed after challenge. A transient reduction in provirus load in the blood early after challenge was observed following env immunization, whilst the gag gene either alone or in combination with env resulted in significantly elevated provirus loads in lung. However, despite this, a significant reduction in lesion score was observed in animals immunized with the single gag gene at post-mortem. Inclusion of IFN-gamma in the immunization mixture in general had no significant effects. The results thus showed that protective effects against VMV-induced lesions can be induced following respiratory immunization with the single gag gene, though this was accompanied by an increased pulmonary provirus load.


Assuntos
Produtos do Gene env/imunologia , Produtos do Gene pol/imunologia , Pneumonia Intersticial Progressiva dos Ovinos/prevenção & controle , Vacinas de DNA/imunologia , Vacinas Virais/imunologia , Vírus Visna-Maedi/imunologia , Animais , Anticorpos Antivirais/sangue , Proliferação de Células , Testes Imunológicos de Citotoxicidade , Feminino , Produtos do Gene env/genética , Produtos do Gene pol/genética , Vetores Genéticos , Leucócitos Mononucleares/imunologia , Pulmão/imunologia , Pulmão/patologia , Pulmão/virologia , Masculino , Nasofaringe/imunologia , Provírus/isolamento & purificação , Índice de Gravidade de Doença , Ovinos , Linfócitos T Citotóxicos/imunologia , Vacinas de DNA/administração & dosagem , Vaccinia virus/genética , Carga Viral , Vacinas Virais/administração & dosagem
14.
Am J Ind Med ; 38(3): 340-8, 2000 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-10940974

RESUMO

BACKGROUND: Chronic, low-level exposure to inorganic lead (Pb) has been involved in a number of human diseases, including tumors. In this study, the effect of four different inorganic Pb compounds (acetate, chloride, monoxide, and sulfate) was evaluated, in vitro, on liver-derived REL cells, known to be very sensitive to tumor promoters. METHODS: Cytotoxicity and effects on intercellular communication (GJIC) were evaluated, respectively, by cell- density/proliferation and dye-transfer assays. Pb concentration in the media solutions used for each treatment was quantified by atomic absorption spectroscopy-electrothermal atomization. RESULTS: Each of the Pb compounds we tested showed a typical dose- and time-related effect on REL cell proliferation, this effect not being related to the free metal concentration. Contrary to classical tumor promoters, none of the compounds significantly affected REL GJIC (1-hour treatment). CONCLUSIONS: Our results are indicative of specificity in the effects of the different Pb compounds. The mechanism(s) of their action need further investigations.


Assuntos
Carcinógenos/efeitos adversos , Chumbo/efeitos adversos , Fígado/efeitos dos fármacos , Fígado/patologia , Animais , Comunicação Celular/efeitos dos fármacos , Contagem de Células , Divisão Celular/efeitos dos fármacos , Linhagem Celular/efeitos dos fármacos , Linhagem Celular/patologia , Epitélio/efeitos dos fármacos , Epitélio/patologia , Junções Intercelulares/efeitos dos fármacos , Compostos Organometálicos/efeitos adversos , Óxidos/efeitos adversos , Ratos
15.
Biochem Biophys Res Commun ; 248(3): 648-54, 1998 Jul 30.
Artigo em Inglês | MEDLINE | ID: mdl-9703980

RESUMO

Transplantation of normal myoblasts into dystrophic muscles is a potential treatment for Duchenne muscular dystrophy (DMD). However, the success of such grafts is limited by the immune system responses. To avoid rejection problems, autologous transplantation of the patient's corrected myoblasts has been proposed. Regretfully, the low proliferative capacity of DMD myoblasts in culture (due to their premature senescence) limits such procedure. On the other hand, modification of dermal fibroblasts leading to the myogenic pathway using a master regulatory gene for myogenesis is an interesting alternative approach. In this study, the retrovirally encoded MyoD1 cDNA was introduced in dermal fibroblasts of TnI LacZ mice to provoke their conversion into myoblast-like cells. In vitro and in vivo assays were done and the results were compared to those obtained with uninfected fibroblasts and myoblasts. Some MyoD1-expressing fibroblasts were able to fuse and to express beta-galactosidase (under the transcriptional control of the Troponin I promoter), dystrophin and desmin in vitro. Thirty days following implantation of these modified fibroblasts in muscles of mdx mice, an average of 7 beta-Gal+/Dys-muscle fibers were observed. No beta-Gal+ fibers were observed after the transplantation of uninfected fibroblasts. Our results indicate that the successful implantation of myoblasts obtained from genetically modified fibroblasts is indeed feasible. However, the in vitro conversion rate and the in vivo fusion of genetically modified fibroblasts must be largely increased to consider this approach as a potential therapy for DMD and other myopathies.


Assuntos
Proteína MyoD/biossíntese , Transplante de Pele/fisiologia , Pele/metabolismo , Animais , Animais Recém-Nascidos , Desmina/biossíntese , Distrofina/biossíntese , Fibroblastos/citologia , Fibroblastos/metabolismo , Fibroblastos/transplante , Camundongos , Camundongos Transgênicos , Regiões Promotoras Genéticas , Codorniz , Proteínas Recombinantes de Fusão/biossíntese , Pele/citologia , Transativadores/biossíntese , Troponina I/genética , beta-Galactosidase/biossíntese
16.
J Biol Chem ; 276(25): 22685-98, 2001 Jun 22.
Artigo em Inglês | MEDLINE | ID: mdl-11297548

RESUMO

The mechanisms by which receptor tyrosine kinases (RTKs) utilize intracellular signaling pathways to direct gene expression and cellular response remain unclear. A current question is whether different RTKs within a single cell target similar or different sets of genes. In this study we have used the ErbB receptor network to explore the relationship between RTK activation and gene expression. We profiled growth factor-stimulated signaling pathway usage and broad gene expression patterns in two human mammary tumor cell lines expressing different complements of ErbB receptors. Although the growth factors epidermal growth factor (EGF) and neuregulin (NRG) 1 similarly stimulated Erk1/2 in MDA-MB-361 cells, EGF acting through an EGF receptor/ErbB2 heterodimer preferentially stimulated protein kinase C, and NRG1beta acting through an ErbB2/ErbB3 heterodimer preferentially stimulated Akt. The two growth factors regulated partially overlapping yet distinct sets of genes in these cells. In MDA-MB-453 cells, NRG1beta acting through an ErbB2/ErbB3 heterodimer stimulated prolonged signaling of all pathways examined relative to NRG2beta acting through the same heterodimeric receptor species. Surprisingly, NRG1beta and NRG2beta also regulated partially overlapping but distinct sets of genes in these cells. These results demonstrate that the activation of different RTKs, or activation of the same RTKs with different ligands, can lead to distinct profiles of gene regulation within a single cell type. Our observations also suggest that the identity and kinetics of signaling pathway usage by RTKs may play a role in the selection of regulated genes.


Assuntos
Fator de Crescimento Epidérmico/metabolismo , Expressão Gênica/fisiologia , Neuregulina-1/metabolismo , Receptores Proteína Tirosina Quinases/fisiologia , Transdução de Sinais/fisiologia , Animais , Humanos , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Células Tumorais Cultivadas
17.
J Immunol ; 159(5): 2522-31, 1997 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-9278346

RESUMO

Myoblast transplantation is a potential treatment for Duchenne muscular dystrophy. One of the problems possibly responsible for the limited success of clinical trials is the rapid death of the myoblasts after transplantation. To investigate this problem, myoblasts expressing beta-galactosidase were injected in the tibialis anterior muscles of mice. Beta-galactosidase activity was reduced by 74.7% after 3 days. Myoblast death observed at 3 days was reduced to 57.2% when the hosts were irradiated. This result suggested that host cells were contributing to this phenomenon. Transplantation in SCID and FK506-treated mice did not reduce cell death, indicating that mortality was not due to an acute specific reaction. In contrast, administration of the anti-LFA-1 (TIB-213) mAb markedly reduced myoblast death at 3 days without altering leukocyte tissue infiltration. We postulated that neutrophils were mediating myoblast mortality by an LFA-1-dependent mechanism. To test this hypothesis, IL-1beta-activated myoblasts were loaded with 6-carboxy-2',7'-dichlorodihydrofluorescein diacetate, di(acetoxymethylester) (DCFH), a marker for oxidative stress. Addition of neutrophils and zymosan-activated serum resulted in a time-dependent DCFH fluorescence; this neutrophil-induced oxidation was considerably inhibited by TIB-213. These results indicate that an effective control of the inflammatory reaction will be necessary for any new clinical trials of myoblast transplantation and suggest that neutrophil-mediated myoblast injury occurs by an LFA-1-dependent pathway.


Assuntos
Anticorpos Monoclonais/farmacologia , Rejeição de Enxerto/patologia , Antígeno-1 Associado à Função Linfocitária/fisiologia , Músculo Esquelético/citologia , Distrofia Muscular Animal/terapia , Transplante de Células-Tronco , Animais , Anti-Inflamatórios/uso terapêutico , Anti-Inflamatórios não Esteroides/uso terapêutico , Anticorpos Monoclonais/uso terapêutico , Apoptose , Biomarcadores , Adesão Celular , Morte Celular , Linhagem Celular Transformada , Fluoresceínas , Genes Reporter , Rejeição de Enxerto/prevenção & controle , Imunossupressores/uso terapêutico , Inflamação , Interleucina-1/farmacologia , Antígeno-1 Associado à Função Linfocitária/imunologia , Antígeno de Macrófago 1/fisiologia , Metilprednisolona/uso terapêutico , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos mdx , Camundongos SCID , Distrofia Muscular Animal/patologia , Naproxeno/uso terapêutico , Necrose , Neutrófilos/imunologia , Neutrófilos/patologia , Estresse Oxidativo , Peroxidase/análise , Piroxicam/uso terapêutico , Quimera por Radiação , Tacrolimo/uso terapêutico , Irradiação Corporal Total , Zimosan/farmacologia , beta-Galactosidase/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA